Published 4 issues per year
ISSN Print: 0731-8898
ISSN Online: 2162-6537
Indexed in
Naringenin Ameliorates Doxorubicin Toxicity and Hypoxic Condition in Dalton's Lymphoma Ascites Tumor Mouse Model: Evidence from Electron Paramagnetic Resonance Imaging
ABSTRACT
Doxorubicin (DOX) is a well-known cytotoxic agent used extensively as a chemotherapeutic drug to eradicate a wide variety of human cancers. Reactive oxygen species (ROS)-mediated oxidative stress during DOX treatment can induce cardiac, renal, and hepatic toxicities, which can constrain its use as a potential cytotoxic agent. The present work investigates the antioxidant potential of naringenin (NAR) against DOXinduced toxicities of a Dalton's lymphoma ascites (DLA) tumor-bearing mouse model. Mice were randomized into four groups: a negative control, positive control, DOX (2.5 mg/kg) treated, and DOX (2.5 mg/kg) + NAR (50 mg/kg/d) treated. DOX administration significantly altered the levels of functional markers in blood and antioxidant enzymes in kidney, heart, lung, liver, spleen, and tumor tissues. These changes in antioxidant enzymes and successive lipid peroxidation were prevented by NAR supplementation, resulting in decreases in the risk of toxicity due to DOX therapy. Histopathology results and electron paramagnetic resonance imaging (EPRI) of the tumor microenvironment confirmed this evidence. Using EPRI, pharmacokinetics of the nitroxide, 3-carbamoyl-2,2,5,5-tetramethylpyrrolidine-1-oxyl (3-CP) was monitored intratumorally before and after chemotherapy. EPRI of the DOX + NAR–treated mouse model showed reduced tumor size with significant modification of the hypoxic condition inside the tumor microenvironment. Consequently, these findings suggest that NAR treatment significantly reduces DOX-induced toxicity and the hypoxic condition in a DLA tumor-bearing mouse model.
-
Shibu Marthandam Asokan, Agrawal Dinesh Chandra, Huang Chih-Yang, Mushrooms: A Pandora Box of Cardioprotective Phytochemicals, in Medicinal Plants and Fungi: Recent Advances in Research and Development, 4, 2017. Crossref
-
Karim Naymul, Jia Zhenquan, Zheng Xiaodong, Cui Sunliang, Chen Wei, A recent review of citrus flavanone naringenin on metabolic diseases and its potential sources for high yield-production, Trends in Food Science & Technology, 79, 2018. Crossref
-
Naraki Karim, Rezaee Ramin, Karimi Gholamreza, A review on the protective effects of naringenin against natural and chemical toxic agents, Phytotherapy Research, 35, 8, 2021. Crossref
-
Masuelli Laura, Benvenuto Monica, Focaccetti Chiara, Ciuffa Sara, Fazi Sara, Bei Arianna, Miele Martino Tony, Piredda Lucia, Manzari Vittorio, Modesti Andrea, Bei Roberto, Targeting the tumor immune microenvironment with “nutraceuticals”: From bench to clinical trials, Pharmacology & Therapeutics, 219, 2021. Crossref
-
Navarro-Hortal María D., Varela-López Alfonso, Romero-Márquez José M., Rivas-García Lorenzo, Speranza Lorenza, Battino Maurizio, Quiles José L., Role of flavonoids against adriamycin toxicity, Food and Chemical Toxicology, 146, 2020. Crossref
-
Utkusavas Ayfer, Gurel Gurevin Ebru, Yilmazer Nadim, Uvez Ayca, Oztay Fusun, Bulut Huri, Ustunova Savas, Esener Osman B. Burak, Sonmez Kivilcim, Erol Kutucu Deniz, Meral Ismail, Dimas Konstantinos, Armutak Elif Ilkay, Effects of combined administration of doxorubicin and chloroquine on lung pathology in mice with solid Ehrlich ascites carcinoma, Biotechnic & Histochemistry, 2022. Crossref